Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Emodepside by Bayer for Ancylostomiasis (Hookworm Infections): Likelihood of Approval
Emodepside is under clinical development by Bayer and currently in Phase II for Ancylostomiasis (Hookworm Infections). According to GlobalData, Phase...